Everolimus Reduces <sup>89</sup>Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.Published in:Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1087, doi. 10.2967/jnumed.113.129056By:van Asselt, Sophie J.;Oosting, Sjoukje F.;Brouwers, Adrienne H.;Bongaerts, Alfons H. H.;de Jong, Johan R.;Lub-de Hooge, Marjolijn N.;Oude Munnink, Thijs H.;Fiebrich, Helle-Brit;Sluiter, Wim J.;Links, Thera R.;Walenkamp, Annemiek M. E.;de Vries, Elisabeth G. E.Publication type:Article